Chris Chen, WuXi Biologics CEO (Anthony Kwan/Bloomberg via Getty Images)

Hunt­ing for ‘cer­tain­ty and sta­bil­i­ty,’ WuXi Bio spot­lights client re­la­tion­ships

WuXi Bi­o­log­ics tout­ed its part­ner­ships and con­tracts in its an­nu­al re­port on Tues­day, not­ing that it has al­most 700 projects in its pipeline, which can …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.